Last updated: 15 June 2019 at 1:58am EST

Anne Marie Duliege Net Worth




The estimated Net Worth of Anne Marie Duliege is at least $570 Tisíc dollars as of 17 September 2018. Anne Duliege owns over 153,000 units of Rigel Pharmaceuticals stock worth over $486,375 and over the last 11 years Anne sold RIGL stock worth over $83,409.

Anne Duliege RIGL stock SEC Form 4 insiders trading

Anne has made over 7 trades of the Rigel Pharmaceuticals stock since 2014, according to the Form 4 filled with the SEC. Most recently Anne exercised 153,000 units of RIGL stock worth $371,790 on 17 September 2018.

The largest trade Anne's ever made was exercising 153,000 units of Rigel Pharmaceuticals stock on 17 September 2018 worth over $371,790. On average, Anne trades about 13,891 units every 100 days since 2014. As of 17 September 2018 Anne still owns at least 37,500 units of Rigel Pharmaceuticals stock.

You can see the complete history of Anne Duliege stock trades at the bottom of the page.



What's Anne Duliege's mailing address?

Anne's mailing address filed with the SEC is C/O CHEMOCENTRYX, INC., 850 MAUDE AVENUE, MOUNTAIN VIEW, CA, 94043.

Insiders trading at Rigel Pharmaceuticals

Over the last 21 years, insiders at Rigel Pharmaceuticals have traded over $170,041,384 worth of Rigel Pharmaceuticals stock and bought 2,068,700 units worth $7,281,949 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Ansbert Gadicke a Partners L P/Ilbiotechnolog.... On average, Rigel Pharmaceuticals executives and independent directors trade stock every 46 days with the average trade being worth of $961,207. The most recent stock trade was executed by David A Santos on 2 February 2024, trading 14,519 units of RIGL stock currently worth $16,552.



What does Rigel Pharmaceuticals do?

rigel pharmaceuticals, inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases.



What does Rigel Pharmaceuticals's logo look like?

Rigel Pharmaceuticals logo

Complete history of Anne Duliege stock trades at ChemoCentryx Inc a Rigel Pharmaceuticals

Datum
#
Společnost
Osoba
Trans.
Transakce
Počet akcií Cena za akcii Celková cena Počet akcií po Zdroj
17 Sep 2018 Anne Marie Duliege
EVP a Chief Medical Officer
Využití opce 153,000 $2.43 $371,790
17 Sep 2018
37,500
4 Sep 2018 Anne Marie Duliege
EVP a Chief Medical Officer
Využití opce 16,500 $2.54 $41,910
4 Sep 2018
16,500
2 Jul 2018 Anne Marie Duliege
EVP a Chief Medical Officer
Prodej 5,000 $2.79 $13,950
2 Jul 2018
0
20 Apr 2018 Anne Marie Duliege
EVP a Chief Medical Officer
Prodej 5,000 $4.11 $20,550
20 Apr 2018
0
5 Jul 2017 Anne Marie Duliege
EVP a Chief Medical Officer
Prodej 5,000 $2.69 $13,450
5 Jul 2017
0
3 Jan 2017 Anne Marie Duliege
EVP a Chief Medical Officer
Prodej 5,000 $2.41 $12,050
3 Jan 2017
0
18 Nov 2014 Anne Marie Duliege
EVP a Chief of Strategic Dev.
Prodej 4,970 $4.71 $23,409
18 Nov 2014
0


Rigel Pharmaceuticals executives and stock owners

Rigel Pharmaceuticals executives and other stock owners filed with the SEC include: